F9Q

6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine

Find entries where: F9Q

is present as a standalone ligand in 1 entries

Find related ligands:

Similar Ligands (Stereospecific)

Similar Ligands (including Stereoisomers)

Similar Ligands (Quick Screen)

Similar Ligands (Substructure Stereospecific)

Similar Ligands (Substructure including Stereoisomers)

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
Identifiers	6-(2-chloranyl-6-methyl-pyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
Formula	C₁₅ H₁₁ Cl F N₅
Molecular Weight	315.733
Type	NON-POLYMER
Isomeric SMILES	Cc1cc(cc(n1)Cl)c2c(nc(nn2)N)c3ccc(cc3)F
InChI	InChI=1S/C15H11ClFN5/c1-8-6-10(7-12(16)19-8)14-13(20-15(18)22-21-14)9-2-4-11(17)5-3-9/h2-7H,1H3,(H2,18,20,22)
InChIKey	NCWQLHHDGDXIJN-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	33
Chiral Atom Count	0
Bond Count	35
Aromatic Bond Count	18

Drug Info: DrugBank

DrugBank ID	DB16192 ?
Name	Imaradenant
Groups	investigational
Description	Imaradenant is under investigation in clinical trial NCT03381274 (Oleclumab (MEDI9447) Egfrm NSCLC Novel Combination Study).
Synonyms	Imaradenant
CAS number	1321514-06-0

Related Resource References

Resource Name	Reference
PubChem	86676119

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.